Company Filing History:
Years Active: 1981-1982
Title: The Innovations of Stephen M Nash
Introduction
Stephen M Nash is a notable inventor based in Greenwood, IN (US). He has made significant contributions to the field of antibiotics, holding two patents that showcase his innovative work. His research has focused on developing antibiotic compounds that have the potential to impact medical treatments.
Latest Patents
Nash's latest patents include Antibiotics A6888C and A6888X. These antibiotic compounds are produced by culturing Streptomyces flocculus NRRL 11459. The compounds are characterized by the formula: ##STR1## wherein R' is ##STR2## or --CH.sub.2 OH, along with their non-toxic pharmaceutically acceptable acid addition salts. The patents also describe techniques for isolating these compounds, which are coproduced with Cirramycin A.sub.1 and Cirramycin B.
Career Highlights
Stephen M Nash is associated with Eli Lilly and Company, a leading pharmaceutical company known for its commitment to innovation in healthcare. His work at Eli Lilly has allowed him to contribute to the development of important antibiotic therapies.
Collaborations
Nash has collaborated with notable coworkers such as Kay F Koch and Marvin M Hoehn. These collaborations have likely enhanced the research and development process, leading to successful innovations in antibiotic compounds.
Conclusion
Stephen M Nash's contributions to antibiotic research and his patents reflect his dedication to advancing medical science. His work continues to influence the field and holds promise for future developments in antibiotic therapies.